GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » Price-to-Tangible-Book

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Price-to-Tangible-Book : 1.21 (As of May. 20, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co Price-to-Tangible-Book?

As of today (2024-05-20), Hunan Er-Kang Pharmaceutical Co's share price is ¥2.59. Hunan Er-Kang Pharmaceutical Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ¥2.15. Hence, Hunan Er-Kang Pharmaceutical Co's Price to Tangible Book Ratio of today is 1.21.

The historical rank and industry rank for Hunan Er-Kang Pharmaceutical Co's Price-to-Tangible-Book or its related term are showing as below:

SZSE:300267' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.2   Med: 2.12   Max: 18.25
Current: 1.2

During the past 13 years, Hunan Er-Kang Pharmaceutical Co's highest Price to Tangible Book Ratio was 18.25. The lowest was 1.20. And the median was 2.12.

SZSE:300267's Price-to-Tangible-Book is ranked better than
79.82% of 867 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs SZSE:300267: 1.20

A closely related ratio is called PB Ratio. As of today, Hunan Er-Kang Pharmaceutical Co's share price is ¥2.59. Hunan Er-Kang Pharmaceutical Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was ¥2.33. Hence, Hunan Er-Kang Pharmaceutical Co's P/B Ratio of today is 1.11.


Hunan Er-Kang Pharmaceutical Co Price-to-Tangible-Book Historical Data

The historical data trend for Hunan Er-Kang Pharmaceutical Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Er-Kang Pharmaceutical Co Price-to-Tangible-Book Chart

Hunan Er-Kang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.99 1.62 2.22 1.58 1.49

Hunan Er-Kang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 1.42 1.49 1.49 1.26

Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Er-Kang Pharmaceutical Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's Price-to-Tangible-Book falls into.



Hunan Er-Kang Pharmaceutical Co Price-to-Tangible-Book Calculation

Hunan Er-Kang Pharmaceutical Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=2.59/2.148
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Hunan Er-Kang Pharmaceutical Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Business Description

Traded in Other Exchanges
N/A
Address
Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331
Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Headlines

No Headlines